<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 PatientsMichal Weiler‐Sagie, Ora Israel, Olga Bushelev et al.|Journal of Nuclear Medicine|2009Cited by 381
Endocrinology: Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapyZeev Blumenfeld, Nissim Haim, I. Avivi et al.|Human Reproduction|1996Cited by 266
Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcomeEldad J. Dann, Ron Epelbaum, Rachel Bar‐Shalom et al.|Blood|2006Cited by 124
Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variablesRon Epelbaum, Yoram Cohen, David Faraggi et al.|Cancer|1990Cited by 122
Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomasNissim Haim, Eliezer Robinson, Ron Epelbaum et al.|Cancer|1994Cited by 114